Hospital minimum volume standards deliver mixed results in the first systematic review of the policy
Minimum volume standards are meant to concentrate care in hospitals that perform enough procedures to preserve skill, reduce error, and improve outcomes. The logic is straightforward: complex surgery and other high-stakes interventions tend to be safer when teams repeat them often enough to maintain technical precision, coordinated workflows, and rescue capacity when complications arise. Yet policy has often moved faster than the evidence. A systematic review in BMJ Open examined whether hospital minimum volume standards actually change patient outcomes, and the answer was far less decisive than many health systems would hope.
Only nine studies met the review’s eligibility criteria, and the results were too heterogeneous for meta-analysis. That alone says something important about the evidence base: policymakers are being asked to act on a small and uneven literature, not on a mature body of comparative effectiveness research. The review used the GRADE approach, searched major medical and health policy databases through June 2023, and restricted inclusion to stronger evaluation designs such as randomized trials, non-randomized trials, controlled before-after studies, and interrupted time series analyses. Even with that level of methodological restraint, the picture remained fragmented.
Travel burden rose as care was concentrated
One of the clearest findings involved travel distance. When minimum volume standards shifted care toward fewer hospitals, patients had to travel farther. That is the predictable geographic trade-off of centralization: improved procedural concentration can come at the cost of access friction, delayed presentation, caregiver strain, and extra logistical burden for patients and families. In systems already strained by rural inequality or long referral chains, longer travel may be more than an inconvenience; it can shape whether patients accept referral, complete follow-up, or present early enough when symptoms worsen.
Length of stay moved in the opposite direction. Hospitals operating under minimum volume rules generally recorded shorter stays, which may reflect more standardized perioperative pathways, tighter discharge planning, or greater familiarity with the covered procedures. Shorter hospitalization can be beneficial when it reflects efficient care rather than premature discharge, but the review did not show that this translated into a broad outcome advantage. The gain in throughput did not clearly come with a parallel reduction in the outcomes that matter most to patients and health systems.
Complications and reoperations did not shift convincingly
Across the included studies, complications and reoperations were not clearly affected by the introduction of minimum volume standards. That result is clinically sobering because these are the very outcomes volume policies are supposed to improve. If higher caseload truly strengthens team performance, one would expect fewer postoperative harms, better recognition of early deterioration, and fewer returns to the operating room. Instead, the review found no consistent signal strong enough to support a firm claim of benefit.
The absence of a visible effect does not prove that volume never matters. It does show that the policy signal is weak in the available evidence and may depend on procedure type, baseline hospital quality, implementation fidelity, and whether the threshold is set meaningfully above existing practice. A minimum volume rule is a blunt instrument. If the threshold is too low, it may simply reorganize care without changing competence. If it is set too high, it may concentrate access without guaranteeing a safer perioperative process.
Mortality evidence remained especially uncertain
Mortality was the most consequential endpoint in the review, yet it was also the least certain. Evidence for in-hospital and 30-day mortality was rated very low. In practical terms, that means the current studies do not support confident conclusions about whether minimum volume standards save lives. The low certainty is not just a statistical label; it reflects serious limitations in study design, residual confounding, and small numbers of studies contributing data for the outcome that matters most.
Seven of the nine included studies carried a serious risk of bias, and the remaining two were judged to have moderate risk of bias. That pattern weakens confidence in every apparent effect, whether favorable or neutral. In policy research, bias is rarely evenly distributed. Hospitals that become subject to volume standards may already differ in staffing, referral pathways, case mix, teaching status, or regional access, and those differences can distort outcomes long before the policy itself is measured.
A policy with plausible biology but weak comparative evidence
The biological and organizational rationale for volume standards remains plausible. Repetition can improve technical skill, multidisciplinary coordination, and postoperative rescue systems. Concentrating complex procedures may also reduce latent variation in device use, anesthesia practice, and escalation protocols. Those mechanisms are credible. They are simply not confirmed by strong empirical evidence in this review.
The review’s most useful contribution may be its restraint. Rather than over-reading a scattered literature, it documents how little robust causal evidence exists for a policy that has already been adopted in several countries. Health systems often reach for volume thresholds because they are easy to communicate and relatively simple to enforce. But the outcome profile here suggests that centralization alone is not a substitute for quality improvement. Procedure count is only one part of the equation; case selection, team composition, perioperative pathways, and access to rescue care may matter just as much.
What health systems should take from the current evidence
For now, the available studies do not provide conclusive evidence that minimum volume standards improve the outcomes most often invoked to justify them. The evidence for mortality remains very low certainty, and the evidence for complications, reoperations, length of stay, and travel distance is low certainty. The review also shows how difficult it is to evaluate policy interventions that are introduced unevenly across hospitals and countries, often without randomized allocation and without uniform outcome reporting.
A stronger evidence base will require designs that can handle the real-world complexity of health system policy. Interrupted time series studies, well-matched controlled comparisons, and analyses with clearer implementation timing would offer more reliable insight than the current patchwork of observational reports. Without that, minimum volume standards will continue to rest more on theory than on definitive patient-centered proof.
For hospital leaders, the practical question is not whether high-volume centers can be better. It is whether a minimum threshold by itself produces enough benefit to justify the access burden it creates. This review does not answer that with confidence, and the uncertainty is greatest where the stakes are highest: survival, major complications, and the long-term consequences of reorganizing care around procedure counts rather than measured quality.